The effect of Curcumex on Type 2 diabetic patients
Phase 3
Recruiting
- Conditions
- diabetes mellitus type 2.
- Registration Number
- IRCT20181028041483N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Baseline A1c <9%
Fasting blood glucose is between 200-126 mg / dl
Patients only use oral hypoglycemic drugs
Duration of diagnosis of diabetes is less than 10 years
Exclusion Criteria
Pregnancy and lactation
Insulin treatment
Sensitization and allergy to black pepper or other ingredients in combination
Significant renal and hepatic failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of people who have fasting blood glucose (200-126 mg / dL). Timepoint: Before the intervention begins and Day 90. Method of measurement: Parsazmoon's FBS kit.;The percentage of people who have glycosylated hemoglobin (9% -7%). Timepoint: Before the intervention begins and Day 90. Method of measurement: Diazyme's HbA1c kit.
- Secondary Outcome Measures
Name Time Method